Richard Law
Stock Analyst at Goldman Sachs
(0)
# 4432
Out of 5,329 analysts
59
Total ratings
30.77%
Success rate
-14.21%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceutica... | Maintains: Neutral | 29 15 | 8.12 | 84.73% | 2 | Mar 3, 2025 | |
CLDX Celldex Therapeutics | Maintains: Neutral | 42 36 | 21.01 | 71.35% | 2 | Mar 3, 2025 | |
MLTX MoonLake | Maintains: Buy | 82 73 | 42.13 | 73.27% | 3 | Feb 27, 2025 | |
MLYS Mineralys Therapeuti... | Maintains: Buy | 28 24 | 15.32 | 56.66% | 6 | Feb 13, 2025 | |
VRDN Viridian Therapeutic... | Maintains: Strong Buy | 25 31 | 13.77 | 125.13% | 2 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 24 | 5.41 | 343.62% | 4 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 | 5.01 | 119.56% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 31 | 5.64 | 449.65% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 47 | 20.26 | 131.98% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 62 63 | 38.79 | 62.41% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 36 37 | 35.16 | 5.23% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 76 | 9.04 | 740.71% | 6 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 36 | n/a | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 14 | 1.66 | 743.37% | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 | 7.16 | 751.96% | 4 | May 8, 2023 |